The standard for treating patients with anemia has long been red blood cell transfusions. That may not be the best treatment for patients hospitalized with the condition.

They key to correcting sickle cell disease may lie in a patient's own stem cells. Researchers have found a way to use the cells in a test tube to create a normal version of the gene.

Taking a diagnostic blood test while hospitalized is a fairly routine process. Most don't think twice about them. But for heart attack patients, such tests could lead to hospital-acquired anemia.

In the United States, there is only one approved aplastic anemia drug today. Doctors pondered whether a potent medication approved in Europe may better treat anemia.

Certain congenital diseases such as sickle cell anemia predominantly affect blacks. The University of Oxford constructed the first detailed genetic map from African American genetic information that may allow for better treatment of such diseases.